HMGB1 and Sepsis: Compared with the vehicle, the GSDMD activation inhibitor obviously reduced the mortality rate and plasma HMGB1 and IL-1β concentrations in the mice with sepsis (Supplemental Figure 9B and Supplemental Figure 10, A and B).